TRIALSITEIQ PUBLIC FEASIBILITY SCORECARD · GRADE C

NCT07885605: Evaluation of ETHY-001 for Safety, Tolerability, and Clinical Activity in Thyroid Eye Disease

Sponsor: Ethyreal Bio, Inc. · Phase: PHASE1 · Area: CARDIOLOGY_METABOLIC · Target Enrollment: 72 pts

Competing Trials Overlap

4 Active Trials

Excess Burn Exposure

$4,221,712

Rescue Site Savings

+$2,776,848

Unlock Full NCT07885605 Backup Super-Site Packet ($49 One-Time Pass)

Download the complete list of top-decile low-cannibalization clinical sites, verified Principal Investigator (PI) direct emails/phones, and protocol optimization benchmarks.

Download $49 NCT07885605 Rescue Dossier →